Yangtze River Pharmaceutical(Group) Co.,
Yangtze River Pharmaceutical Group (hereinafter referred to as YRPG) is a Chinese large-scale cross-region pharmaceutical group founded in 1971. Till July 2019, with a total area of over 3 million square meters, YRPG owns 14 manufacturing subsidiaries located in Beijing, Shanghai, Nanjing, Guangzhou etc. and has established R&D and production bases of innovative chemical medicine, patent traditional Chinese medicine (TCMs) and biological medicines.
4 workshops, 6 FDFs and 1 NEX had been EU GMP certified (Enalapril Maleate Tablets, Omeprazole Enteric-coated Capsules, Nifedipine Prolonged Release Tablets, Glimepiride Tablets, Sotalol Hydrochloride Tablets, Gingko Biloba Tablets and Gingko Biloba Extract). Omeprazole Capsules was exported to Germany in 2012. 79 FDFs have been exported to 25 countries/areas in Europe, Asia and Africa. From 2012 to 2018, YRPG was awarded Top 1 among Top 100 Enterprises in China Chemical Pharmaceutical Industry.
From 2014 to 2018, YRPG was awarded Top 1 among Top 100 Enterprises in China Pharmaceutical Industry.
In 2016, YRPG was honored Global Performance Excellence Award (World Class).
In 2016 and 2018, YRPG was honored Nomination of China Quality Award.
In 2016 and 2019, YRPG was honored Top 1 among China Brand Evaluation of Bio-pharmaceutical Field (both brand power and brand value).
|Sales markets||Eastern Europe; Middle East; Asia; North America; Africa; Central/South America|
|Affiliated categories:||Antibiotics |Antineoplastic / Chemotherapeutic agent / Anthracyclines |API Contract Manufacturing More|
CPhI Worldwide 20195-7 November 2019 Frankfurt, Germany We were at stand 90C50 See our Exhibitor Profile See full Exhibitor List
CPHI Middle East & Africa 201916 -18 September 2019 ADNEC, Abu Dhabi, UAE We were at stand H63 See our Exhibitor Profile See full Exhibitor List
Our Top products
News about Yangtze River Pharmaceutical(Group) Co.,
22 Jul 2019
Yangtze River Pharmaceutical Group achieved Double Winners of 2019 China Brand Evaluation
Yangtze River Pharmaceutical Group achieved the double winners in China pharmaceutical field with Brand Value of RMB 42.869 billion and Brand Strength of 980 points, and became veritable No.1 brand in China pharmaceutical industry.Read more
Categories affiliated with Yangtze River Pharmaceutical(Group) Co.,
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation